positionForPages[74]={page:74,positions:[{w:"66",p:[0.092505,0.957873,0.109687,0.957873,0.109687,0.938882,0.092505,0.938882,0.008591,0.008591]},{w:"3",p:[0.038824,0.310836,0.060302,0.310836,0.060302,0.263358,0.038824,0.263358,0.021478]},{w:"CHAPTER 3",p:[0.117647,0.067219,0.190423,0.067219,0.190423,0.047140,0.117647,0.047140,0.009172,0.009650,0.008799,0.008861,0.007388,0.007906,0.009359,0.003320,0.008321]},{w:"and targeted drugs. Drugs were selected based on clinical practice or evaluation in clinical ",p:[0.117647,0.121273,0.857048,0.121273,0.857048,0.100900,0.117647,0.100900,0.009085,0.011596,0.011391,0.002876,0.006551,0.009085,0.007624,0.009656,0.009131,0.006209,0.009108,0.011391,0.002876,0.011391,0.007967,0.011413,0.009724,0.007670,0.004497,0.002876,0.016024,0.007967,0.011413,0.009724,0.007670,0.002876,0.014518,0.009039,0.007442,0.009039,0.002876,0.007875,0.008948,0.005182,0.009108,0.009108,0.006209,0.009108,0.011391,0.002876,0.011117,0.009291,0.007875,0.009106,0.011391,0.002876,0.010843,0.011756,0.002876,0.008765,0.005250,0.005615,0.011756,0.005547,0.009106,0.009405,0.005250,0.002876,0.011069,0.007898,0.009291,0.009108,0.006437,0.005547,0.008994,0.009039,0.002876,0.010845,0.007807,0.002876,0.009334,0.009838,0.009405,0.004908,0.011596,0.008811,0.006437,0.005547,0.010843,0.011756,0.002876,0.005615,0.011756,0.002876,0.008768,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004109]},{w:"trials for ovarian cancer or solid tumors in general. Drug response experiments were ",p:[0.117647,0.141852,0.856961,0.141852,0.856961,0.121479,0.117647,0.121479,0.006437,0.007807,0.005798,0.009405,0.005250,0.007670,0.006551,0.006026,0.010843,0.007807,0.006551,0.010866,0.009838,0.009085,0.007807,0.005798,0.009085,0.011756,0.006551,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.006551,0.010843,0.007807,0.006551,0.007875,0.010934,0.005250,0.005547,0.011391,0.006551,0.006163,0.011413,0.017485,0.010843,0.007624,0.007670,0.006551,0.005615,0.011756,0.006551,0.009656,0.009039,0.011596,0.009039,0.007898,0.009405,0.004976,0.004497,0.006551,0.016024,0.007967,0.011413,0.009861,0.006551,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.006551,0.009108,0.010089,0.011505,0.009039,0.007807,0.005615,0.017485,0.009039,0.011391,0.006437,0.007670,0.006551,0.014518,0.009039,0.007442,0.009039,0.004109]},{w:"performed in technical replicates and replicate AUC values highly correlated (R²=0.87) ",p:[0.117647,0.162431,0.857139,0.162431,0.857139,0.142058,0.117647,0.142058,0.011505,0.009039,0.007807,0.006026,0.010843,0.007807,0.017485,0.009108,0.011391,0.005045,0.005615,0.011756,0.005045,0.006209,0.009108,0.008765,0.011459,0.011756,0.005547,0.009108,0.009402,0.005250,0.005045,0.007442,0.009131,0.011162,0.005250,0.005547,0.009106,0.008811,0.006209,0.009039,0.007670,0.005045,0.009085,0.011596,0.011391,0.005045,0.007442,0.009131,0.011162,0.005250,0.005547,0.009108,0.008811,0.006209,0.009039,0.005045,0.013513,0.016024,0.014678,0.005045,0.009838,0.009405,0.004908,0.011345,0.009039,0.007670,0.005045,0.011459,0.005615,0.009930,0.011573,0.005182,0.009724,0.005045,0.008994,0.010843,0.007807,0.007442,0.008948,0.005433,0.008811,0.006209,0.009108,0.011391,0.005045,0.006939,0.013376,0.007099,0.011779,0.010432,0.004497,0.010432,0.010432,0.006939,0.004109]},{w:"(",p:[0.117647,0.183009,0.124586,0.183009,0.124586,0.162636,0.117647,0.162636,0.006939]},{w:"Figure S3A",p:[0.124586,0.183009,0.226097,0.183009,0.226097,0.161876,0.124586,0.161876,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.006734,0.010592,0.010911,0.015089]},{w:"). Passage numbers at which PDOs were screened for drug response are ",p:[0.226104,0.183009,0.857034,0.183009,0.857034,0.162636,0.226104,0.162636,0.006939,0.004497,0.006894,0.011413,0.009291,0.007531,0.007946,0.009199,0.009653,0.009039,0.006894,0.011391,0.011413,0.017394,0.011254,0.009039,0.007624,0.007670,0.006894,0.008811,0.006437,0.006894,0.014789,0.011459,0.005547,0.008765,0.011459,0.006894,0.011664,0.016504,0.016253,0.007670,0.006894,0.014518,0.009039,0.007442,0.009039,0.006894,0.007875,0.008994,0.007442,0.009108,0.009039,0.011596,0.009108,0.011391,0.006894,0.006026,0.010843,0.007807,0.006894,0.011391,0.007967,0.011413,0.009861,0.006894,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.006894,0.009087,0.007442,0.009039,0.004109]},{w:"provided in ",p:[0.117647,0.203588,0.220938,0.203588,0.220938,0.183215,0.117647,0.183215,0.011071,0.007442,0.010866,0.009838,0.005547,0.011322,0.009108,0.011391,0.005227,0.005615,0.011756,0.004109]},{w:"Table S1",p:[0.222043,0.203588,0.296686,0.203588,0.296686,0.182455,0.222043,0.182455,0.011413,0.009679,0.011528,0.005935,0.009473,0.005113,0.010592,0.010911]},{w:". PDOs were classified into a low-responsive subgroup if the drug ",p:[0.296677,0.203588,0.857120,0.203588,0.857120,0.183215,0.296677,0.183215,0.004497,0.005227,0.011664,0.016504,0.016253,0.007670,0.005227,0.014518,0.009039,0.007442,0.009039,0.005227,0.008765,0.005433,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.011391,0.005227,0.005615,0.011391,0.006209,0.011048,0.005227,0.009291,0.005227,0.005182,0.010866,0.014723,0.007533,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.005227,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.005227,0.005615,0.006209,0.005227,0.006620,0.011299,0.009039,0.005227,0.011391,0.007967,0.011413,0.009861,0.004109]},{w:"concentration that reduced viability of >50% of cells (IC50-value) was higher than the ",p:[0.117647,0.224167,0.857004,0.224167,0.857004,0.203794,0.117647,0.203794,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.005684,0.006620,0.011391,0.008811,0.006437,0.005684,0.007442,0.009108,0.011046,0.011347,0.008994,0.009108,0.011391,0.005684,0.009838,0.005798,0.009108,0.010820,0.005752,0.005250,0.005273,0.006437,0.009724,0.005684,0.010843,0.006209,0.005684,0.011550,0.010432,0.010432,0.015043,0.005684,0.010843,0.006209,0.005684,0.008994,0.008948,0.005387,0.005250,0.007670,0.005684,0.006939,0.006825,0.014678,0.010432,0.010432,0.007533,0.009838,0.009402,0.004908,0.011345,0.009039,0.006939,0.005684,0.014723,0.009291,0.007670,0.005684,0.011459,0.005615,0.009930,0.011299,0.009039,0.007807,0.005684,0.006620,0.011391,0.009085,0.011756,0.005684,0.006620,0.011299,0.009039,0.004109]},{w:"concentration achievable in patient plasma (concentration steady state, maximum ",p:[0.117647,0.244745,0.857121,0.244745,0.857121,0.224373,0.117647,0.224373,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.010181,0.009291,0.008765,0.011459,0.005547,0.009336,0.009838,0.009108,0.010911,0.005182,0.009039,0.010181,0.005615,0.011756,0.010181,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.010181,0.011162,0.005433,0.009291,0.007601,0.017577,0.009291,0.010181,0.006939,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.010181,0.007510,0.006209,0.009291,0.009291,0.011322,0.009724,0.010181,0.007510,0.006551,0.008811,0.006209,0.008743,0.004497,0.010181,0.017577,0.009291,0.010089,0.005615,0.017280,0.011413,0.017645,0.004109]},{w:"concentration (C /C",p:[0.117647,0.265324,0.299556,0.265324,0.299556,0.244951,0.117647,0.244951,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.004771,0.006939,0.014678,0.015159,0.007099,0.014678]},{w:"ss max",p:[0.262623,0.265793,0.339343,0.265793,0.339343,0.243771,0.262623,0.243771,0.007464,0.007693,0.021776,0.017805,0.011185,0.010797]},{w:"; ",p:[0.339342,0.265324,0.347948,0.265324,0.347948,0.244951,0.339342,0.244951,0.004497,0.004109]},{w:"Table S3",p:[0.348613,0.265324,0.422812,0.265324,0.422812,0.244191,0.348613,0.244191,0.011413,0.009679,0.011528,0.005935,0.009473,0.004668,0.010592,0.010911]},{w:")",p:[0.422811,0.265324,0.429750,0.265324,0.429750,0.244951,0.422811,0.244951,0.006939]},{w:"288,289",p:[0.429750,0.257708,0.468862,0.257708,0.468862,0.245831,0.429750,0.245831,0.006082,0.006082,0.006082,0.002622,0.006082,0.006082,0.006082]},{w:", and a high-responsive subgroup if the IC50-",p:[0.468860,0.265324,0.852921,0.265324,0.852921,0.244951,0.468860,0.244951,0.004497,0.004771,0.009085,0.011596,0.011391,0.004771,0.009291,0.004771,0.011459,0.005615,0.009930,0.011459,0.007533,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.004771,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.004771,0.005615,0.006209,0.004771,0.006620,0.011299,0.009039,0.004771,0.006825,0.014678,0.010432,0.010432,0.007533]},{w:"value was lower than the Css/Cmax.",p:[0.117647,0.285903,0.420670,0.285903,0.420670,0.265530,0.117647,0.265530,0.009838,0.009405,0.004908,0.011345,0.009039,0.004109,0.014723,0.009291,0.007670,0.004109,0.005182,0.010866,0.014518,0.009039,0.007807,0.004109,0.006617,0.011393,0.009085,0.011756,0.004109,0.006617,0.011302,0.009039,0.004109,0.014678,0.007531,0.007670,0.007099,0.014609,0.017577,0.009291,0.010089,0.004497]},{w:"Divergent responses were observed to chemotherapeutic drugs carboplatin (platinum/",p:[0.117647,0.306482,0.853012,0.306482,0.853012,0.286109,0.117647,0.286109,0.016024,0.005547,0.009633,0.009039,0.007624,0.009656,0.009039,0.011391,0.006437,0.005341,0.007442,0.009039,0.007512,0.011502,0.010843,0.011619,0.007875,0.009039,0.007670,0.005341,0.014518,0.009039,0.007442,0.009039,0.005341,0.010957,0.010934,0.007875,0.009039,0.008398,0.009635,0.009108,0.011391,0.005341,0.006209,0.011048,0.005341,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011505,0.009131,0.011071,0.006437,0.005547,0.008994,0.005341,0.011391,0.007967,0.011413,0.009724,0.007670,0.005341,0.009108,0.009085,0.007715,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.005341,0.006939,0.011162,0.005433,0.008811,0.006437,0.005615,0.011391,0.011413,0.017645,0.007099]},{w:"alkylating agent), paclitaxel (taxane/antimicrotubule agent) and gemcitabine (pyrimi-",p:[0.117647,0.327060,0.852941,0.327060,0.852941,0.306687,0.117647,0.306687,0.009405,0.005387,0.010455,0.009793,0.005433,0.008811,0.006437,0.005615,0.011459,0.009861,0.007008,0.009197,0.009656,0.009039,0.011393,0.006437,0.006939,0.004497,0.006996,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.007008,0.006939,0.006549,0.009291,0.010089,0.009085,0.011596,0.009039,0.007099,0.009085,0.011391,0.006437,0.005615,0.017645,0.005547,0.008994,0.007442,0.010820,0.006163,0.011345,0.010797,0.011550,0.005182,0.009039,0.007008,0.009199,0.009656,0.009039,0.011391,0.006437,0.006939,0.007008,0.009085,0.011596,0.011391,0.007008,0.009656,0.009039,0.017485,0.008994,0.005273,0.006551,0.009108,0.010820,0.005615,0.011596,0.009039,0.007008,0.006939,0.011094,0.009724,0.007807,0.005615,0.017645,0.005558,0.007533]},{w:"dine antagonist) (",p:[0.117647,0.347639,0.268945,0.347639,0.268945,0.327266,0.117647,0.327266,0.011391,0.005615,0.011596,0.009039,0.005866,0.009085,0.011393,0.006551,0.009199,0.009653,0.010845,0.011756,0.005615,0.007510,0.006437,0.006939,0.005866,0.006939]},{w:"Figure 2A-C; Table S3",p:[0.268954,0.347639,0.466577,0.347639,0.466577,0.326506,0.268954,0.326506,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.005741,0.010911,0.014358,0.007213,0.014769,0.005433,0.005741,0.011413,0.009679,0.011528,0.005935,0.009473,0.005741,0.010592,0.010911]},{w:"). A minority of PDOs was classified into the ",p:[0.466577,0.347639,0.857006,0.347639,0.857006,0.327266,0.466577,0.327266,0.006939,0.004497,0.005866,0.014929,0.005866,0.017645,0.005615,0.011596,0.010843,0.007807,0.005273,0.006437,0.009724,0.005866,0.010843,0.006209,0.005866,0.011664,0.016504,0.016253,0.007670,0.005866,0.014723,0.009291,0.007670,0.005866,0.008768,0.005430,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.011391,0.005866,0.005615,0.011391,0.006209,0.011048,0.005866,0.006620,0.011299,0.009039,0.004109]},{w:"high-responsive subgroup of carboplatin (7/31, 23%) and paclitaxel monotherapy (5/31, ",p:[0.117647,0.368218,0.857086,0.368218,0.857086,0.347845,0.117647,0.347845,0.011459,0.005615,0.009930,0.011459,0.007533,0.007442,0.009039,0.007510,0.011502,0.010845,0.011619,0.007601,0.005547,0.009633,0.009039,0.003926,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011069,0.011276,0.003926,0.010843,0.006209,0.003926,0.009108,0.009085,0.007715,0.011254,0.010820,0.011160,0.005433,0.008813,0.006437,0.005615,0.011756,0.003915,0.006939,0.010432,0.007099,0.010432,0.010432,0.004497,0.003915,0.010432,0.010432,0.015043,0.006939,0.003915,0.009085,0.011598,0.011391,0.003915,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.003915,0.017485,0.010845,0.011596,0.010820,0.006617,0.011302,0.009039,0.007896,0.008813,0.011092,0.009724,0.003926,0.006939,0.010432,0.007099,0.010432,0.010432,0.004497,0.004109]},{w:"16%), while most PDOs (29/35, 83%) were in the high-responsive subgroup of gemcit-",p:[0.117647,0.388796,0.852941,0.388796,0.852941,0.368423,0.117647,0.368423,0.010432,0.010432,0.015043,0.006939,0.004497,0.005182,0.014789,0.011459,0.005752,0.005182,0.009039,0.005182,0.017485,0.010955,0.007512,0.006437,0.005182,0.011664,0.016504,0.016253,0.007670,0.005182,0.006939,0.010432,0.010432,0.007099,0.010432,0.010432,0.004497,0.005182,0.010432,0.010432,0.015043,0.006939,0.005182,0.014518,0.009039,0.007442,0.009039,0.005182,0.005615,0.011756,0.005182,0.006620,0.011299,0.009039,0.005182,0.011459,0.005615,0.009930,0.011459,0.007533,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.005182,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.005182,0.010843,0.006209,0.005182,0.009653,0.009039,0.017488,0.008994,0.005273,0.006437,0.007533]},{w:"abine. Response also correlated with OC histological subtype, all LGS-samples showed ",p:[0.117647,0.409375,0.857048,0.409375,0.857048,0.389002,0.117647,0.389002,0.009108,0.010820,0.005615,0.011596,0.008743,0.004497,0.005102,0.013696,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005102,0.009405,0.005250,0.007875,0.011048,0.005102,0.008994,0.010843,0.007807,0.007442,0.008946,0.005435,0.008809,0.006211,0.009106,0.011391,0.005102,0.014723,0.005273,0.006620,0.011459,0.005102,0.016778,0.014678,0.005102,0.011459,0.005615,0.007510,0.006209,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.005102,0.007510,0.011345,0.010797,0.006437,0.009724,0.011502,0.008745,0.004497,0.005102,0.009405,0.005385,0.005250,0.005102,0.011528,0.015682,0.010112,0.007533,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.005102,0.007556,0.011302,0.010863,0.014520,0.009106,0.011391,0.004109]},{w:"low responsiveness to paclitaxel and carboplatin monotherapy (except for response to ",p:[0.117647,0.429954,0.857004,0.429954,0.857004,0.409581,0.117647,0.409581,0.005182,0.010866,0.014723,0.005889,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.011596,0.009039,0.007533,0.007670,0.005889,0.006209,0.011048,0.005889,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.005889,0.009085,0.011596,0.011391,0.005889,0.009108,0.009085,0.007715,0.011251,0.010822,0.011160,0.005433,0.008811,0.006437,0.005615,0.011756,0.005889,0.017485,0.010843,0.011596,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011094,0.009724,0.005889,0.006939,0.009108,0.009884,0.008994,0.009131,0.011048,0.006437,0.005889,0.006026,0.010843,0.007807,0.005889,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005889,0.006209,0.011048,0.004109]},{w:"carboplatin in LGS-3.1), while the high responsiveness was restricted to HG(S)-sam-",p:[0.117647,0.450532,0.852941,0.450532,0.852941,0.430160,0.117647,0.430160,0.009108,0.009085,0.007715,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.006745,0.005615,0.011756,0.006745,0.011528,0.015682,0.010112,0.007533,0.010432,0.004497,0.010432,0.006939,0.004497,0.006743,0.014792,0.011459,0.005752,0.005182,0.009039,0.006745,0.006620,0.011299,0.009039,0.006745,0.011459,0.005615,0.009930,0.011459,0.006745,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.011596,0.009039,0.007533,0.007670,0.006757,0.014723,0.009291,0.007670,0.006745,0.007442,0.009039,0.007510,0.006437,0.007807,0.005547,0.009108,0.006209,0.009106,0.011391,0.006757,0.006209,0.011048,0.006745,0.016412,0.015682,0.006939,0.010112,0.006939,0.007533,0.007944,0.009085,0.017624,0.007533]},{w:"ples. For certain PDOs, combination treatment with two chemotherapeutic drugs had a ",p:[0.117647,0.471111,0.857073,0.471111,0.857073,0.450738,0.117647,0.450738,0.011162,0.005182,0.009039,0.007670,0.004497,0.004360,0.010683,0.010843,0.007807,0.004360,0.008994,0.009039,0.007967,0.006551,0.009085,0.005615,0.011756,0.004360,0.011664,0.016504,0.016253,0.007670,0.004497,0.004360,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.004360,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004360,0.014723,0.005273,0.006620,0.011459,0.004360,0.006437,0.014518,0.011048,0.004360,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011505,0.009131,0.011071,0.006437,0.005547,0.008994,0.004360,0.011391,0.007967,0.011413,0.009722,0.007670,0.004360,0.011391,0.009291,0.011391,0.004360,0.009291,0.004109]},{w:"greater effect on viability (lower IC50 values) than the drugs’ individual effects (",p:[0.117647,0.491690,0.773139,0.491690,0.773139,0.471317,0.117647,0.471317,0.009861,0.007442,0.009291,0.008811,0.006209,0.009039,0.007807,0.003447,0.009039,0.005969,0.005787,0.009108,0.009108,0.006437,0.003447,0.010843,0.011756,0.003447,0.009838,0.005798,0.009108,0.010820,0.005752,0.005250,0.005273,0.006437,0.009724,0.003447,0.006939,0.005182,0.010866,0.014518,0.009039,0.007807,0.003447,0.006825,0.014678,0.010432,0.010432,0.003447,0.009838,0.009405,0.004908,0.011345,0.009039,0.007670,0.006939,0.003447,0.006620,0.011391,0.009085,0.011756,0.003447,0.006620,0.011299,0.009039,0.003447,0.011391,0.007967,0.011413,0.009724,0.006277,0.004291,0.003447,0.005615,0.011596,0.011391,0.005547,0.009838,0.005547,0.011046,0.011596,0.009405,0.005250,0.003447,0.009039,0.005969,0.005787,0.009108,0.009108,0.006437,0.007670,0.003447,0.006939]},{w:"Table S3",p:[0.773104,0.491690,0.846002,0.491690,0.846002,0.470557,0.773104,0.470557,0.011413,0.009679,0.011528,0.005935,0.009473,0.003367,0.010592,0.010911]},{w:") ",p:[0.846002,0.491690,0.857050,0.491690,0.857050,0.471317,0.846002,0.471317,0.006939,0.004109]},{w:"indicating either an additive or synergistic effect of the combined drugs. Our results, for ",p:[0.117647,0.512269,0.857118,0.512269,0.857118,0.491896,0.117647,0.491896,0.005615,0.011596,0.011391,0.005547,0.009108,0.008811,0.006437,0.005615,0.011459,0.009861,0.004337,0.009039,0.005273,0.006620,0.011299,0.009039,0.007807,0.004337,0.009085,0.011756,0.004337,0.009291,0.011322,0.011391,0.005273,0.006437,0.005547,0.009633,0.009039,0.004337,0.010843,0.007807,0.004337,0.007759,0.009724,0.011598,0.009039,0.007622,0.009861,0.005615,0.007510,0.006437,0.005547,0.008994,0.004337,0.009039,0.005969,0.005787,0.009108,0.009108,0.006437,0.004337,0.010843,0.006209,0.004337,0.006620,0.011299,0.009039,0.004337,0.008994,0.010843,0.017394,0.010820,0.005615,0.011596,0.009108,0.011391,0.004337,0.011391,0.007964,0.011413,0.009726,0.007670,0.004497,0.004337,0.016504,0.011413,0.007807,0.004337,0.007442,0.009039,0.007510,0.011550,0.004908,0.006437,0.007670,0.004497,0.004337,0.006024,0.010845,0.007807,0.004109]},{w:"example, showed that carboplatin and paclitaxel treatment alone had minimal effect on ",p:[0.117647,0.532847,0.857073,0.532847,0.857073,0.512474,0.117647,0.512474,0.009108,0.010089,0.009085,0.017280,0.011162,0.005182,0.008743,0.004497,0.004657,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.004657,0.006620,0.011391,0.008811,0.006437,0.004657,0.009108,0.009085,0.007715,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.004657,0.009085,0.011596,0.011391,0.004657,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.004657,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004657,0.009405,0.005182,0.010843,0.011596,0.009039,0.004657,0.011391,0.009291,0.011391,0.004657,0.017645,0.005615,0.011756,0.005615,0.017577,0.009405,0.005250,0.004657,0.009039,0.005969,0.005787,0.009108,0.009106,0.006437,0.004657,0.010843,0.011756,0.004109]},{w:"LGS-3.1 with an IC50-value of 1.46 and >2.5 log μM, respectively, while the IC50-value ",p:[0.117647,0.553426,0.857050,0.553426,0.857050,0.533053,0.117647,0.533053,0.011528,0.015682,0.010112,0.007533,0.010432,0.004497,0.010432,0.004552,0.014723,0.005273,0.006620,0.011459,0.004552,0.009087,0.011756,0.004552,0.006825,0.014678,0.010432,0.010432,0.007533,0.009838,0.009405,0.004908,0.011345,0.009039,0.004552,0.010845,0.006209,0.004552,0.010432,0.004497,0.010432,0.010432,0.004554,0.009085,0.011596,0.011391,0.004554,0.011550,0.010432,0.004497,0.010432,0.004552,0.005182,0.011048,0.009861,0.004554,0.010957,0.019608,0.004497,0.004554,0.007442,0.009039,0.007510,0.011505,0.009106,0.009108,0.006437,0.005547,0.009633,0.008948,0.005184,0.007989,0.004497,0.004552,0.014792,0.011459,0.005752,0.005182,0.009039,0.004554,0.006620,0.011299,0.009039,0.004552,0.006825,0.014678,0.010432,0.010432,0.007533,0.009838,0.009405,0.004908,0.011345,0.009039,0.004109]},{w:"of carboplatin and paclitaxel was reduced to 0.56 and -0.34 log μM in the combination ",p:[0.117647,0.574005,0.857067,0.574005,0.857067,0.553632,0.117647,0.553632,0.010843,0.006209,0.005068,0.009108,0.009085,0.007715,0.011251,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.005068,0.009085,0.011596,0.011391,0.005068,0.011368,0.009291,0.008765,0.005250,0.005273,0.006549,0.009291,0.009884,0.008948,0.005250,0.005068,0.014723,0.009291,0.007670,0.005068,0.007442,0.009108,0.011046,0.011347,0.008994,0.009106,0.011391,0.005068,0.006209,0.011048,0.005068,0.010432,0.004497,0.010432,0.010432,0.005056,0.009085,0.011596,0.011391,0.005068,0.007533,0.010432,0.004497,0.010432,0.010432,0.005056,0.005182,0.011048,0.009861,0.004987,0.010957,0.019608,0.005068,0.005615,0.011756,0.005056,0.006620,0.011299,0.009039,0.005068,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.004109]},{w:"treatment.",p:[0.117647,0.594583,0.204914,0.594583,0.204914,0.574210,0.117647,0.574210,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004497]}]};